Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Lymphangiography in Gastric Cancer
NCT04591028Phase 4Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Jan 2022
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in gastric cancer (GC), sponsored by Mayo Clinic. Planned start Jan 2022; status: withdrawn.
02
Drugs
indocyanine green
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04591028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04591028.